Lunch will be provided. Attendees will be admitted on a first-come basis.
Supported by Urovant Sciences.
This presentation theater discusses the clinical proﬁle and prescribing information for GEMTESA® for the treatment of overactive bladder. The presentation also reviews challenges associated with overactive bladder in long-term care.
4/27/22 2:50 pm
she is a good speaker, the topic is very practical.